{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:48:45Z","timestamp":1791071325325,"version":"4.1.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1086\/515554","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T00:54:57Z","timestamp":1196816097000},"page":"843-846","source":"Crossref","is-referenced-by-count":45,"title":["Point Prevalence of Oropharyngeal Carriage of Fluconazole\u2010Resistant<i>Candida<\/i>in Human Immunodeficiency Virus\u2013Infected Patients"],"prefix":"10.1093","volume":"25","author":[{"given":"Marcelo D.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lozano\u2010Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Rex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"p_2_17","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199105000-00007"},{"key":"p_3_18","first-page":"64","volume":"18","author":"Samaranayake LP","year":"1989","journal-title":"J Oral Pathol Med"},{"key":"p_4_19","unstructured":"Korting HC, Ollert M, Georgii A, Froschl M. In vitro susceptibilities and 14. Centers for Disease Control and Prevention. 1993 revised classiAEcation biotypes of Candida albicans isolates from the oral cavities of patients system for HIV infection and expanded surveillance case deAEnition for infected with human immunodeAEciency virus. J Clin Microbiol 1988; AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 26:2626 0 31. 1992; 41(RR-17):1 0 19."},{"key":"p_5_20","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90300-X"},{"key":"p_6_21","first-page":"47","volume":"24","author":"Chryssanthou E","year":"1997","journal-title":"Clin Infect Dis"},{"key":"p_7_22","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Rhine-Chalberg J, Redding SW, etal Variations in Oucona- 17. Sanglard D, Kuchler K, Ischer F, Pagani J-L, Monod M, Bille J. Mechazole susceptibility and electrophoretic karyotype among oral isolates of nisms of resistance to azole antifungal agents in Candida albicans iso-Candida albicans from patients with AIDS and oral candidiasis. J Clin lates from AIDS patients involve speciAEc multidrug transporters. Anti-Microbiol 1994; 32:59 0 64. microb Agents Chemother 1995; 39:2378 0 86.","DOI":"10.1128\/AAC.39.11.2378"},{"key":"p_8_23","doi-asserted-by":"crossref","unstructured":"Redding S, Smith J, Farinacci G, etal Resistance of Candida albicans to 18. Geber A, Hitchcock CA, Swartz JE, et al. Deletion of the Candida glabrata Ouconazole during treatment of oropharyngeal candidiasis in a patient ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol with AIDS: documentation by in vitro susceptibility testing and DNA composition, and antifungal susceptibility. Antimicrob Agents Chemosubtype analysis. Clin Infect Dis 1994; 18:240 0 2. ther 1995; 39:2708 0 17.","DOI":"10.1128\/AAC.39.12.2708"},{"key":"p_9_24","doi-asserted-by":"crossref","unstructured":"Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR. 19. Vanden Bossche H, Marichal P, Gorrens J, Bellens D, Moereels H, Janssen Correlation of in vitro Ouconazole resistance of Candida isolates in PAJ. Mutation in cytochrome P-450-dependent 14 a-demethylase results relation to therapy and symptoms of individuals seropositive for human in decreased afAEnity for azole antifungals. Biochem Soc Trans 1990; immunodeAEciency virus type 1. Antimicrob Agents Chemother 1993; 18:56 0 9. 37:2449 0 53. 20. Vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene M-C. Char","DOI":"10.1042\/bst0180056"},{"key":"p_10_25","doi-asserted-by":"crossref","unstructured":"Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann acterization of an azole-resistant Candida glabrata isolate. Antimicrob M. Emergence of Ouconazole-resistant strains of Candida albicans in Agents Chemother 1992; 36:2602 0 10. patients with recurrent oropharyngeal candidosis and human immunode- 21. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD, for the NIAID AEciency virus infection. J Clin Microbiol 1994; 32:2092 0 8. Mycoses Study Group and the Candidemia Study Group. Antifungal","DOI":"10.1128\/JCM.32.9.2092-2098.1994"},{"key":"p_11_26","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199406000-00010"},{"key":"p_12_27","first-page":"4","volume":"39","author":"Maenza JR","year":"1995","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/25\/4\/843\/936602\/25-4-843.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T03:58:21Z","timestamp":1684123101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/515554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1086\/515554"],"URL":"https:\/\/doi.org\/10.1086\/515554","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}